Kovai Medical Center and Hospital Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026. The certificate was filed with BSE Limited on 6th April 2026, confirming the dematerialization of physical share certificates during Q4FY26.

Dematerialization Activity Summary

The company's registrar and share transfer agent, GNSA Infotech Private Limited, processed dematerialization requests during the quarter. The quarterly activity details are presented below:

Regulatory Compliance Process

Company Secretary R. Ponmanikandan submitted the certificate to BSE Limited's Corporate Relationship Department, referencing the company's Security ID: KOVAI. The certificate confirms that GNSA Infotech Private Limited, acting as the authorized registrar, has completed all necessary verification procedures for the dematerialization process.

Certification Details

GNSA Infotech Private Limited, through authorized signatory N. Kirshakumar, certified compliance with two key regulatory requirements. The registrar confirmed that all securities comprised in the processed certificates have been listed on stock exchanges and that the physical certificates have been properly mutilated and cancelled following due verification. The depository's name has been substituted in the company's records as the registered owner, completing the dematerialization process.

Previous Regulatory Filings

This filing follows the company's recent submission of promoter declarations for FY2026, where promoters confirmed no encumbrance on their shareholdings. The consistent regulatory compliance demonstrates the company's adherence to SEBI guidelines and commitment to maintaining transparency in its corporate governance practices.

Kovai Medical Center and Hospital Limited 's Board of Directors has approved the re-appointment of two Independent Directors for their second terms, marking a significant governance development for the NABH-accredited healthcare institution. Following the Board meeting held on March 6, 2026, the company has now issued a formal postal ballot notice to shareholders for approval of these re-appointments.

Board Meeting Outcomes and Postal Ballot Notice

The Board meeting, which commenced at 11:00 a.m. and concluded at 11:45 a.m., addressed key governance matters related to the company's leadership structure. The directors approved the re-appointment of both Independent Directors for second terms of five years each, subject to shareholder approval through postal ballot. On March 10, 2026, the company issued the postal ballot notice pursuant to Regulation 30 of the SEBI LODR Regulations.

E-voting Timeline and Process

The company has engaged National Securities Depository Limited (NSDL) for facilitating the e-voting process. Key timeline details for the postal ballot are outlined below:

Independent Directors Re-appointment Details

The Board approved the re-appointment of two key Independent Directors with specific effective dates and terms:

Director Profiles and Expertise

Both directors bring distinct professional backgrounds to the Board. Mr. A.P. Ammaisaikutti is a businessman with interests in the textile industry and holds an Economics Graduate qualification. He manages and leads a group of textile mills, handling overall operations and administrative functions while representing various industry and trade bodies. Additionally, he is involved in philanthropic activities.

Dr. K. Kolandaswamy brings extensive public health expertise with a Post Graduate degree in Applied Epidemiology and professional education in Public Health and Family Welfare management. With 30 years of experience in the Government of Tamil Nadu as a Public Health Service Expert, he has multiple published papers and presentations. His major projects include Helpline for Epidemics Control, and he is currently involved in epidemic control activities including COVID-19 pandemic management.

Regulatory Compliance and Shareholder Communication

The company has submitted the requisite disclosure pursuant to SEBI LODR read with SEBI Circular dated November 11, 2024. The formal communication was sent to BSE Limited's Corporate Relationship Department, ensuring full regulatory compliance for the re-appointment process. The postal ballot notice is being sent only through electronic mode to members whose email addresses are registered with the Company, Registrar and Transfer Agent, or Depositories as per MCA Circulars.

Both directors maintain their independence with no shareholding in the company and no disclosed relationships between directors, ensuring compliance with corporate governance requirements. The postal ballot process ensures that shareholders have the opportunity to vote on these important governance decisions, maintaining transparency in the company's decision-making process.